As of 2026-09-20, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -4.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 326.96 mil USD. EDIT's TTM EBITDA according to its financial statements is -81.14 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 21.2x | 15.6x |
| Forward P/E multiples | 12.8x - 16.6x | 14.2x |
| Fair Price | (5.76) - (7.27) | (6.47) |
| Upside | -313.2% - -369.1% | -339.5% |
| Date | EV/EBITDA |
| 2026-09-17 | -4.31 |
| 2026-09-16 | -4.05 |
| 2026-09-15 | -3.88 |
| 2026-09-14 | -4.11 |
| 2026-09-11 | -4.03 |
| 2026-09-10 | -3.93 |
| 2026-09-09 | -4.17 |
| 2026-09-08 | -4.71 |
| 2026-09-04 | -5.13 |
| 2026-09-03 | -4.82 |
| 2026-09-02 | -4.82 |
| 2026-09-01 | -4.79 |
| 2026-08-31 | -4.77 |
| 2026-08-28 | -4.98 |
| 2026-08-27 | -5.27 |
| 2026-08-26 | -5.02 |
| 2026-08-25 | -5.23 |
| 2026-08-24 | -4.65 |
| 2026-08-21 | -4.88 |
| 2026-08-20 | -4.53 |
| 2026-08-19 | -5.17 |
| 2026-08-18 | -4.40 |
| 2026-08-17 | -4.32 |
| 2026-08-14 | -4.28 |
| 2026-08-13 | -4.26 |
| 2026-08-12 | -4.32 |
| 2026-08-11 | -4.55 |
| 2026-08-10 | -4.26 |
| 2026-08-07 | -4.40 |
| 2026-08-06 | -4.44 |
| 2026-08-05 | -4.13 |
| 2026-08-04 | -4.17 |
| 2026-08-03 | -3.93 |
| 2026-07-31 | -3.78 |
| 2026-07-30 | -4.01 |
| 2026-07-29 | -3.82 |
| 2026-07-28 | -3.86 |
| 2026-07-27 | -3.99 |
| 2026-07-24 | -3.82 |
| 2026-07-23 | -4.09 |
| 2026-07-22 | -4.20 |
| 2026-07-21 | -4.42 |
| 2026-07-20 | -4.40 |
| 2026-07-17 | -4.61 |
| 2026-07-16 | -4.40 |
| 2026-07-15 | -4.73 |
| 2026-07-14 | -4.98 |
| 2026-07-13 | -4.98 |
| 2026-07-10 | -5.19 |
| 2026-07-09 | -5.27 |